This week's View explores the impact of anticoagulation therapy after bioprosthetic aortic valve replacement on valve hemodynamics and clinical outcomes, the relative clinical benefit of adding alirocumab to statins in acute coronary syndrome patients with prior coronary artery bypass grafting, and whether the achievement of N-terminal pro-B-type natriuretic peptide to ≤1000 pg/ml at 90 days with guideline-directed medical therapy predicts outcomes.

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Valvular Heart Disease, ACS and Cardiac Biomarkers, Anticoagulation Management and ACS, Anticoagulation Management and Atrial Fibrillation, Anticoagulation Management and Venothromboembolism, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Cardiac Surgery and VHD, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and ACS, Interventions and Imaging, Interventions and Structural Heart Disease, Interventions and Vascular Medicine, Angiography, Echocardiography/Ultrasound, Nuclear Imaging, Hypertension

Keywords: EaglesEyeView, Acute Coronary Syndrome, Angina, Unstable, Anticoagulants, Aortic Valve, Apolipoproteins B, Atrial Fibrillation, Biomarkers, Bioprosthesis, Brain Ischemia, Cardiac Surgical Procedures, Cardiomyopathies, Cholesterol, HDL, Coronary Artery Bypass, Coronary Disease, Diabetes Mellitus, Type 2, Dyslipidemias, Echocardiography, Evidence-Based Practice, Fibrinolytic Agents, Heart Failure, Heart Valve Diseases, Heart Valve Prosthesis, Hemodynamics, Hospitalization, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypertension, Lipoproteins, Myocardial Infarction, Myocardial Revascularization, Natriuretic Peptide, Brain, Natriuretic Peptides, Outcome Assessment, Health Care, Peptide Fragments, Primary Prevention, Quality of Life, Renal Insufficiency, Chronic, Risk Factors, Secondary Prevention, Stroke, Stroke Volume, Thrombosis, Transcatheter Aortic Valve Replacement, Treatment Outcome, Vascular Diseases, Venous Thromboembolism, Vitamin K, Arrhythmias, Cardiac, Coronary Angiography, Diagnostic Imaging

< Back to Listings